Reference miRNAs for miRNAome analysis of urothelial carcinomas

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Ratert, Nadine ^a,b   Meyer, Hellmuth Alexander ^a   Jung, Monika ^a   Mollenkopf, Hans Joachim ^c   Wagner, Ina ^c   Miller, Kurt ^a   Kilic, Ergin ^a   Erbersdobler, Andreas ^d   Weikert, Steffen ^a   Jung, Klaus ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Berlin Institute for Urologic Research   (Germany)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 101; MICRORNA 125A 5P; MICRORNA 148B; MICRORNA 151 5P; MICRORNA 181A; MICRORNA 181B; MICRORNA 29C; MICRORNA 324 3P; MICRORNA 424; MICRORNA 874; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENE EXPRESSION; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; TRANSITIONAL CELL CARCINOMA; UPREGULATION;

AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

EID: 84862702761     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039309     Document Type: Article

References (58)

1. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
2. Zhang B, Pan X, Cobb GP, Anderson TA, (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12.
3. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, et al. (2007) Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 25: 387-392.
4. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, et al. (2004) An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 101: 9740-9744.
5. Mestdagh P, Van VP, De WA, Muth D, Westermann F, et al. (2009) A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 10: R64.
6. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.
7. Bustin SA, (2002) Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29: 23-39.
8. Tricarico C, Pinzani P, Bianchi S, Paglierani M, Distante V, et al. (2002) Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem 309: 293-300.
9. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control gene. Genome Biol 3: RESEARCH0034.
10. Andersen CL, Jensen JL, Orntoft TF, (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250.
11. Dheda K, Huggett JF, Chang JS, Kim LU, Bustin SA, et al. (2005) The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Anal Biochem 344: 141-143.
12. Ohl F, Jung M, Xu C, Stephan C, Rabien A, et al. (2005) Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization? J Mol Med 83: 1014-1024.
13. Wotschofsky Z, Meyer HA, Jung M, Fendler A, Wagner I, et al. (2011) Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. Anal Biochem 417: 233-241.
14. Lee PD, Sladek R, Greenwood CM, Hudson TJ, (2002) Control genes and variability: absence of ubiquitous reference transcripts in diverse mammalian expression studies. Genome Res 12: 292-297.
15. Kessler Y, Helfer-Hungerbuehler AK, Cattori V, Meli ML, Zellweger B, et al. (2009) Quantitative TaqMan real-time PCR assays for gene expression normalisation in feline tissues. BMC Mol Biol 10: 106.
16. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
17. Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, et al. (2009) MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 219: 214-221.
18. Catto JW, Miah S, Owen HC, Bryant H, Myers K, et al. (2009) Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res 69: 8472-8481.
19. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, et al. (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69: 4851-4860.
20. Friedman JM, Liang G, Liu CC, Wolff EM, Tsai YC, et al. (2009) The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 69: 2623-2629.
21. Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, et al. (2009) Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 125: 345-352.
22. Lin T, Dong W, Huang J, Pan Q, Fan X, et al. (2009) MicroRNA-143 as a tumor suppressor for bladder cancer. J Urol 181: 1372-1380.
23. Hanke M, Hoefig K, Merz H, Feller AC, Kausch I, et al. (2010) A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol 28: 655-661.
24. Neely LA, Rieger-Christ KM, Neto BS, Eroshkin A, Garver J, et al. (2010) A microRNA expression ratio defining the invasive phenotype in bladder tumors. Urol Oncol 28: 39-48.
25. Song T, Xia W, Shao N, Zhang X, Wang C, et al. (2010) Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev 11: 905-911.
26. Han Y, Chen J, Zhao X, Liang C, Wang Y, et al. (2011) MicroRNA expression signatures of bladder cancer revealed by deep sequencing. PLoS One 6: e18286.
27. Cao Y, Yu SL, Wang Y, Guo GY, Ding Q, et al. (2011) MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Tumour Biol 32: 179-188.
28. Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, et al. (2011) MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology. Cancer Sci 102: 522-529.
29. Villadsen SB, Bramsen JB, Ostenfeld MS, Wiklund ED, Fristrup N, et al. (2012) The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer. Br J Cancer 106: 366-374.
30. Ostenfeld MS, Bramsen JB, Lamy P, Villadsen SB, Fristrup N, et al. (2010) miR-145 induces caspase-dependent and-independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene 29: 1073-1084.
31. Lin Y, Wu J, Chen H, Mao Y, Liu Y, et al. (2012) Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells. FEBS Lett 586: 442-447.
32. Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, et al. (2011) miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Int J Oncol 39: 13-21.
33. Wiklund ED, Bramsen JB, Hulf T, Dyrskjot L, Ramanathan R, et al. (2011) Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer 128: 1327-1334.
34. Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, et al. (2011) The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 104: 808-818.
35. Hirata H, Hinoda Y, Ueno K, Shahryari V, Tabatabai ZL, et al. (2012) MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Carcinogenesis 33: 41-48.
36. Wang G, Zhang H, He H, Tong W, Wang B, et al. (2010) Up-regulation of microRNA in bladder tumor tissue is not common. Int Urol Nephrol 42: 95-102.
37. Chang KH, Mestdagh P, Vandesompele J, Kerin MJ, Miller N, (2010) MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 10: 173.
38. Davoren PA, McNeill RE, Lowery AJ, Kerin MJ, Miller N, (2008) Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 9: 76.
39. Schaefer A, Jung M, Miller K, Lein M, Kristiansen G, et al. (2010) Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp Mol Med 42: 749-758.
40. Shen Y, Li Y, Ye F, Wang F, Wan X, et al. (2011) Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues. Exp Mol Med 43: 358-366.
41. van der Kwast TH, Bapat B, (2009) Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling. Curr Opin Urol 19: 516-521.
42. Schaefer A, Stephan C, Busch J, Yousef GM, Jung K, (2010) Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat Rev Urol 7: 286-297.
43. Wszolek MF, Rieger-Christ KM, Kenney PA, Gould JJ, Silva NB, et al. (2011) A MicroRNA expression profile defining the invasive bladder tumor phenotype. Urol Oncol 29: 794-801.
44. Adam L, Zhong M, Choi W, Qi W, Nicoloso M, et al. (2009) miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clin Cancer Res 15: 5060-5072.
45. Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, et al. (2010) miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 102: 883-891.
46. Huang L, Luo J, Cai Q, Pan Q, Zeng H, et al. (2011) MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer 128: 1758-1769.
47. Fendler A, Stephan C, Yousef GM, Jung K, (2011) MiRNAs as regulators of signal transduction in urological tumors. Clin Chem 57: 954-968.
48. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP, (2004) Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol Lett 26: 509-515.
49. Sobin LH, Wittekind C, (2002) TNM classification of malignant tumours. New York: Wiley-Liss. 199 p.
50. Magi-Galluzzi C, Zhou M, Epstein JI, (2007) Neoplasms of the urinary bladder. In: Zhou M, Magi-Galluzzi C, editors. pp. 154-224 editors. Genitourinary pathology. Philadelphia: Churchill Livingstone Elsevier.
51. Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, et al. (2009) MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 13: 3918-3928.
52. Hellemans J, Mortier G, De PA, Speleman F, Vandesompele J, (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.
53. Masotti A, Caputo V, Da SL, Pizzuti A, Dallapiccola B, et al. (2009) Quantification of small non-coding RNAs allows an accurate comparison of miRNA expression profiles. J Biomed Biotechnol 2009: 659028.
54. D'haene B, Mestdagh P, Hellemans J, Vandesompele J, (2012) miRNA expression profiling: from reference genes to global mean normalization. Methods Mol Biol 822: 261-272.
55. Latham GJ, (2010) Normalization of microRNA quantitative RT-PCR data in reduced scale experimental designs. Methods Mol Biol 667: 19-31.
56. Peltier HJ, Latham GJ, (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852.
57. Jung M, Schaefer A, Steiner I, Kempkensteffen C, Stephan C, et al. (2010) Robust microRNA stability in degraded RNA preparations from human tissue and cell samples. Clin Chem 56: 998-1006.
58. Carlsson J, Helenius G, Karlsson M, Lubovac Z, Andren O, et al. (2010) Validation of suitable endogenous control genes for expression studies of miRNA in prostate cancer tissues. Cancer Genet Cytogenet 202: 71-75.